Heart Failure Readmissions: A Deep Dive into Patient Demographics, Comorbidities, and Systemic Challenges
Article Sidebar
Main Article Content
Abstract
Background: Heart failure (HF) is a leading cause of hospital readmissions, presenting significant challenges in healthcare. Comorbid conditions like diabetes and hypertension are prevalent among HF patients and may complicate disease management. Understanding these dynamics is crucial for developing effective intervention strategies.
Objective: This study aims to analyze the factors contributing to HF readmissions, focusing on patient demographics, comorbidities, and systemic healthcare challenges.
Methods: A comprehensive, retrospective cohort analysis was conducted at a tertiary care cardiac center. The study included 1,000 patients with a documented history of HF and instances of hospital readmissions. Patient selection was based on age (≥18 years), a diagnosis of HF, and readmission within six months post-discharge. Exclusion criteria included planned readmissions for elective procedures and cognitive impairments impeding consent. Data collection encompassed patient demographics, clinical history, comorbidity details, initial hospitalization, and readmission information. Descriptive statistics were employed to analyze and summarize the data.
Results: The cohort comprised 80% male (n=800) and 20% female (n=200) with a mean age of 58 years. The median hospital stay was 6 days. Comorbidities included diabetes (78%, n=780) and hypertension (56%, n=560). The primary cause of HF was ischemic cardiomyopathy (82%, n=820). The leading reasons for readmission were lack of counseling (42%, n=420), underdosage of medication (16%, n=160), and non-compliance to medication (13%, n=130). Other factors included volume overload (11%, n=110), secondary hypertensive failure (9%, n=90), infections (6%, n=60), anemia (2%, n=20), and progressive renal failure (1%, n=10).
Conclusion: The study highlights the complexity of managing HF, emphasizing the need for comprehensive approaches addressing patient education, medication management, and comorbidity control. Improved patient counseling and adherence to treatment regimens could significantly reduce HF readmissions.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Agarwal MA, Fonarow GC, Ziaeian B. National trends in heart failure hospitalizations and readmissions from 2010 to 2017. JAMA cardiology. 2021;6(8):952-6.
Roger VL. Epidemiology of heart failure: a contemporary perspective. Circulation research. 2021;128(10):1421-34.
Al-Tamimi MA-A, Gillani SW, Abd Alhakam ME, Sam KG. Factors associated with hospital readmission of heart failure patients. Frontiers in pharmacology. 2021;12:732760.
Wolfe JD, Joynt Maddox KE. Heart failure and the affordable care act: past, present, and future. JACC: Heart Failure. 2019;7(9):737-45.
Ferro EG, Secemsky EA, Wadhera RK, Choi E, Strom JB, Wasfy JH, et al. Patient readmission rates for all insurance types after implementation of the hospital readmissions reduction program. Health Affairs. 2019;38(4):585-93.
Wideqvist M, Cui X, Magnusson C, Schaufelberger M, Fu M. Hospital readmissions of patients with heart failure from real world: timing and associated risk factors. ESC heart failure. 2021;8(2):1388-97.
Awan SE, Bennamoun M, Sohel F, Sanfilippo FM, Chow BJ, Dwivedi G. Feature selection and transformation by machine learning reduce variable numbers and improve prediction for heart failure readmission or death. PloS one. 2019;14(6):e0218760.
Reddy YN, Borlaug BA, editors. Readmissions in heart failure: it’s more than just the medicine. Mayo Clinic Proceedings; 2019: Elsevier.
Wang N, Gallagher R, Sze D, Hales S, Tofler G. Predictors of frequent readmissions in patients with heart failure. Heart, Lung and Circulation. 2019;28(2):277-83.
Su A, Al'Aref SJ, Beecy AN, Min JK, Karas MG, editors. Clinical and socioeconomic predictors of heart failure readmissions: a review of contemporary literature. Mayo Clinic Proceedings; 2019: Elsevier.
Kwok CS, Abramov D, Parwani P, Ghosh RK, Kittleson M, Ahmad FZ, et al. Cost of inpatient heart failure care and 30-day readmissions in the United States. International Journal of Cardiology. 2021;329:115-22.
Sandhu AT, Heidenreich PA. Comparison of the change in heart failure readmission and mortality rates between hospitals subject to hospital readmission reduction program penalties and critical access hospitals. American Heart Journal. 2019;209:63-7.
Patil S, Shah M, Patel B, Agarwal M, Ram P, Alla VM, editors. Readmissions among patients admitted with acute decompensated heart failure based on income quartiles. Mayo Clinic Proceedings; 2019: Elsevier.
Lahewala S, Arora S, Tripathi B, Panaich S, Kumar V, Patel N, et al. Heart failure: same-hospital vs. different-hospital readmission outcomes. International journal of cardiology. 2019;278:186-91.
Gupta R, Maitz T, Egeler D, Mehta A, Nyaeme M, Hajra A, et al. SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure. Trends in cardiovascular medicine. 2022.
Blecker S, Herrin J, Li L, Yu H, Grady JN, Horwitz LI. Trends in hospital readmission of medicare-covered patients with heart failure. Journal of the American College of Cardiology. 2019;73(9):1004-12.
Ryan CJ, Bierle R, Vuckovic KM. The three Rs for preventing heart failure readmission: review, reassess, and reeducate. Critical care nurse. 2019;39(2):85-93.
Senot C. Continuity of care and risk of readmission: An investigation into the healthcare journey of heart failure patients. Production and Operations Management. 2019;28(8):2008-30.
Psotka MA, Fonarow GC, Allen LA, Joynt Maddox KE, Fiuzat M, Heidenreich P, et al. The hospital readmissions reduction program: nationwide perspectives and recommendations: a JACC: heart failure position paper. JACC: Heart Failure. 2020;8(1):1-11.
Foroutan F, Rayner DG, Ross HJ, Ehler T, Srivastava A, Shin S, et al. Global comparison of readmission rates for patients with heart failure. Journal of the American College of Cardiology. 2023;82(5):430-44.
Upadhyay S, Stephenson AL, Smith DG. Readmission rates and their impact on hospital financial performance: a study of Washington hospitals. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2019;56:0046958019860386.
Sevilla-Cazes J, Ahmad FS, Bowles KH, Jaskowiak A-L, Gallagher TR, Goldberg LR, et al. Heart Failure Home Management Challenges and Reasons for Readmission: a Qualitative Study to Understand the Patient’s Perspective. Journal of General Internal Medicine. 2018;33:1700-7.
Retrum JH, Boggs JM, Hersh AM, Wright LA, Main DS, Magid DJ, et al. Patient-Identified Factors Related to Heart Failure Readmissions. Circulation: Cardiovascular Quality and Outcomes. 2013;6:171–7.
Dong R, Mutharasan RK. The Role of Process Improvements in Reducing Heart Failure Readmissions. Journal of Clinical Outcomes Management. 2020;27:184-90.
Iyngkaran P, Liew D, Neil C, Driscoll A, Marwick TH, Hare DL. Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age. Clinical Medicine Insights Cardiology. 2018;12.